4.6 Article

A quantum chemical study on the anti-SARS-CoV-2 activity of TMPRSS2 inhibitors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Experimental Models of SARS-CoV-2 Infection: Possible Platforms to Study COVID-19 Pathogenesis and Potential Treatments

Sareh Pandamooz et al.

Summary: This review discusses the development and usage of experimental models to study and screen potential therapeutic approaches against SARS-CoV-2, including antiviral drugs and vaccines. These models provide valuable insights into the cellular tropism, replication kinetics, and cell damage caused by SARS-CoV-2, ultimately enhancing understanding of viral pathogenesis and protective immunity.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)

Article Virology

In Silico Analysis and Synthesis of Nafamostat Derivatives and Evaluation of Their Anti-SARS-CoV-2 Activity

Kazuhiro J. Fujimoto et al.

Summary: This study investigates the crucial elements that cause the difference in anti-SARS-CoV-2 activity of nafamostat and camostat, and indicates that the ease of covalent bond formation with Ser441 in TMPRSS2 possibly plays a major role in the anti-SARS-CoV-2 effect of nafamostat and its derivatives.

VIRUSES-BASEL (2022)

Review Chemistry, Physical

The role of quantum chemistry in covalent inhibitor design

Levente M. Mihalovits et al.

Summary: The recent rise of targeted covalent inhibitors in drug discovery presents new opportunities and challenges for quantum chemical reactivity calculations. These calculations are crucial in determining inhibitory potency by predicting intrinsic reactivities of covalent ligands. Mixed quantum mechanical/molecular mechanical potentials provide a comprehensive description of covalent ligand binding mechanisms, while efficient QM/MM predictions of ligand reactivities are highly useful in covalent drug discovery.

INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY (2022)

Review Immunology

Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

Zhan Zhang et al.

Summary: COVID-19, caused by SARS-CoV-2, is a major threat to public health worldwide; vaccination is crucial in managing the disease. Vaccines enhance immune response and reduce transmission, but continuous development is needed due to viral variations. Vaccine research is urgent for pandemic elimination.

FRONTIERS IN IMMUNOLOGY (2022)

Article Infectious Diseases

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson et al.

Summary: A study quantified the global impact of the first year of COVID-19 vaccination programs, finding that the vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. However, inadequate access to vaccines in low-income countries has limited the impact, reinforcing the need for global vaccine equity and coverage.

LANCET INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation

Bryan J. Fraser et al.

Summary: This study provides insights into the structure and function of TMPRSS2, a key protein involved in the viral entry and pathogenesis of SARS-CoV-2. By studying its structure and cleavage sites, the researchers also uncovered the specificity of TMPRSS2, which can aid in drug development efforts.

NATURE CHEMICAL BIOLOGY (2022)

Article Multidisciplinary Sciences

The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2

Jonathan E. Pekar et al.

Summary: Understanding the circumstances that lead to pandemics is crucial for their prevention. In this study, the genomic diversity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early in the coronavirus disease 2019 (COVID-19) pandemic was analyzed. The results suggest that before February 2020, SARS-CoV-2 likely consisted of two distinct viral lineages, labeled A and B. Through phylodynamic rooting methods and epidemic simulations, it was revealed that these lineages were the result of at least two separate cross-species transmission events into humans. The findings indicate that widespread circulation of SARS-CoV-2 in humans before November 2019 is unlikely, and define the narrow time window between the first jump of SARS-CoV-2 into humans and the first reported cases of COVID-19.

SCIENCE (2022)

Article Biochemistry & Molecular Biology

Systematic Down-Selection of Repurposed Drug Candidates for COVID-19

Christopher A. MacRaild et al.

Summary: SARS-CoV-2 is the cause of the COVID-19 pandemic, and the development of new drugs and vaccines is critical in managing it. Repurposing approved drugs has been an effective method for developing new treatments quickly. By applying filters and evaluating the activity of thousands of compounds, researchers have identified 12 FDA-approved drugs with potential mechanisms for treating COVID-19.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Genetics & Heredity

COVID-19 2022 update: transition of the pandemic to the endemic phase

Michela Biancolella et al.

Summary: This article reviews the current state of research on COVID-19, including its history, human genetics and genomics, and the transition from the pandemic to the endemic phase. The lack of solid information in the initial phases of the pandemic is highlighted, emphasizing the need for better preparation to face similar future threats. The progress in human genetic susceptibility investigations is appreciated, and there is a call for global vigilance and cooperation in the transition to the endemic phase.

HUMAN GENOMICS (2022)

Article Infectious Diseases

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson et al.

Summary: The study estimated that COVID-19 vaccination has prevented millions of deaths globally between December 8, 2020, and December 8, 2021. Achieving the vaccination coverage targets set by COVAX and WHO could have prevented even more deaths. However, limited access to vaccines in low-income countries has hindered the impact, highlighting the importance of global vaccine equity.

LANCET INFECTIOUS DISEASES (2022)

Article Medicine, Research & Experimental

Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in iPS cells

Rina Hashimoto et al.

Summary: This study investigated the roles of neuropilin-1, basigin, TMPRSSs, and CTSs in SARS-CoV-2 infection using the CRISPR interference system and ACE2-expressing human iPS cells. Double knockdown of TMPRSS2 and CTSB significantly reduced the viral load. Combination of CTPB and TMPRSS2 inhibitors showed highly efficient antiviral effects against various SARS-CoV-2 variants, independent of gender.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Biochemistry & Molecular Biology

Quantum simulations of SARS-CoV-2 main protease Mpro enable high-quality scoring of diverse ligands

Yuhang Wang et al.

Summary: The COVID-19 pandemic has accelerated drug discovery efforts, with computational chemistry methods showing great potential for efficiently triaging potential candidates, particularly in identifying small molecule inhibitors.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2021)

Article Chemistry, Multidisciplinary

Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat

Tim Hempel et al.

Summary: The study elucidates the molecular mechanism of camostat and nafamostat inhibiting the entry of SARS-CoV-2 into human lung cells and provides a model of the drugs binding to TMPRSS2. Nafamostat is found to have a higher propensity to form a stable covalent enzyme-substrate intermediate compared to camostat, explaining its higher potency.

CHEMICAL SCIENCE (2021)

Article Chemistry, Medicinal

Evaluating QM/MM Free Energy Surfaces for Ranking Cysteine Protease Covalent Inhibitors

Clauber H. S. da Costa et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Article Pharmacology & Pharmacy

Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits

Weimei Sun et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)

Review Chemistry, Multidisciplinary

Structure-based design of targeted covalent inhibitors

Richard Lonsdale et al.

CHEMICAL SOCIETY REVIEWS (2018)

Review Pharmacology & Pharmacy

Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview

Veronica Salmaso et al.

FRONTIERS IN PHARMACOLOGY (2018)

Review Chemistry, Medicinal

Covalent inhibitors design and discovery

Stephane De Cesco et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Review Chemistry, Multidisciplinary

Ligand-Binding Affinity Estimates Supported by Quantum-Mechanical Methods

Ulf Ryde et al.

CHEMICAL REVIEWS (2016)

Article Chemistry, Medicinal

Role of Molecular Dynamics and Related Methods in Drug Discovery

Marco De Vivo et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Review Chemistry, Multidisciplinary

The ONIOM Method and Its Applications

Lung Wa Chung et al.

CHEMICAL REVIEWS (2015)

Article Biochemistry & Molecular Biology

Arginine: Its pKa value revisited

Carolyn A. Fitch et al.

PROTEIN SCIENCE (2015)

Article Chemistry, Physical

A Density Functional with Spherical Atom Dispersion Terms

Amy Austin et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)

Article Chemistry, Multidisciplinary

Fully ab initio protein-ligand interaction energies with dispersion corrected density functional theory

Jens Antony et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)

Review Chemistry, Multidisciplinary

Quantum mechanical continuum solvation models

J Tomasi et al.

CHEMICAL REVIEWS (2005)

Article Chemistry, Multidisciplinary

Development and testing of a general amber force field

JM Wang et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Review Biochemistry & Molecular Biology

Principles of docking: An overview of search algorithms and a guide to scoring functions

I Halperin et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2002)